SEC
JAZZ icon

Seven Eight Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Seven Eight Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,432
Closed -$686K – 841
2024
Q2 		$686K Buy
+6,432
New +$707K 0.07% 455
2024
Q1 		– Sell
-9,529
Closed -$1.17M – 719
2023
Q4 		$1.17M Buy
+9,529
New +$1.19M 0.14% 220
2019
Q3 		– Sell
-24,517
Closed -$3.5M – 658
2019
Q2 		$3.5M Sell
24,517
-16,693
-41% -$2.24M 0.18% 160
2019
Q1 		$5.89M Buy
41,210
+27,100
+192% +$3.53M 0.31% 100
2018
Q4 		$1.75M Buy
+14,110
New +$2.09M 0.1% 267
2017
Q3 		– Sell
-4,500
Closed -$700K – 523
2017
Q2 		$700K Sell
4,500
-12,400
-73% -$1.9M 0.1% 264
2017
Q1 		$2.45M Sell
16,900
-11,200
-40% -$1.46M 0.48% 53
2016
Q4 		$3.06M Buy
+28,100
New +$3.13M 0.62% 26
2016
Q3 		– Sell
-500
Closed -$71K – 445
2016
Q2 		$71K Sell
500
-3,900
-89% -$575K 0.02% 424
2016
Q1 		$574K Buy
+4,400
New +$548K 0.24% 133
2015
Q4 		– Sell
-1,800
Closed -$239K – 610
2015
Q3 		$239K Buy
+1,800
New +$310K 0.21% 164
2015
Q2 		– Sell
-2,700
Closed -$467K – 589
2015
Q1 		$467K Buy
+2,700
New +$463K 0.78% 22
2014
Q2 		– Sell
-2,200
Closed -$305K – 561
2014
Q1 		$305K Buy
+2,200
New +$331K 0.26% 151

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Seven Eight Capital's JAZZ Position: Q3 2024 in Review

Seven Eight Capital sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 6,432 shares — an estimated $686K sold.

Seven Eight Capital first reported a position in JAZZ in Q1 2014 and held it in 13 quarters. The position peaked at $5.89M in Q1 2019. 477 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • Seven Eight Capital reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Seven Eight Capital sold 6,432 Jazz Pharmaceuticals shares in Q3 2024, an estimated $686K.
  • Seven Eight Capital first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 13 quarters.
  • Seven Eight Capital's Jazz Pharmaceuticals position peaked at $5.89M in Q1 2019.
  • 477 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.